{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:53Z","timestamp":1790674133722,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.hoc.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T17:49:02Z","timestamp":1562176142000},"page":"739-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Existing and Emerging Blood-Borne Pathogens"],"prefix":"10.1016","volume":"33","author":[{"given":"Stephen J.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Leiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hoc.2019.05.002_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.hoc.2019.05.002_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika virus infection in man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib3","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.hoc.2019.05.002_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3201\/eid2006.140138","article-title":"Zika virus, French Polynesia, South Pacific, 2013","volume":"20","author":"Cao-Lormeau","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.hoc.2019.05.002_bib5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","article-title":"Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.hoc.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1590\/0074-02760150192","article-title":"First report of autochthonous transmission of Zika virus in Brazil","volume":"110","author":"Zanluca","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.hoc.2019.05.002_bib7","series-title":"Brazilian government (Brazil), M.d.S., Minist\u00e9rio da Sa\u00fade divulga boletim epidemiol\u00f3gico sobre microcefalia","year":"2015"},{"issue":"3","key":"10.1016\/j.hoc.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15585\/mmwr.mm6503e1","article-title":"Zika virus spreads to new areas - region of the Americas, May 2015-January 2016","volume":"65","author":"Hennessey","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.hoc.2019.05.002_bib9","series-title":"Estimated potential range of Aedes aegypti and Aedes albopictus in the United States","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.hoc.2019.05.002_bib10","series-title":"Cumulative Zika virus disease case counts in the United States, 2015-2018","author":"Centers for Disease Control and Prevention","year":"2018"},{"issue":"10047","key":"10.1016\/j.hoc.2019.05.002_bib11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(16)30902-3","article-title":"Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation","volume":"388","author":"Franca","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1605367","article-title":"Zika and the risk of microcephaly","volume":"375","author":"Johansson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib13","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/trf.13681","article-title":"Probable transfusion-transmitted Zika virus in Brazil","volume":"56","author":"Barjas-Castro","year":"2016","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.hoc.2019.05.002_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMc1607262","article-title":"Evidence for transmission of Zika virus by platelet transfusion","volume":"375","author":"Motta","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.hoc.2019.05.002_bib15","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.14.20761","article-title":"Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014","volume":"19","author":"Musso","year":"2014","journal-title":"Euro Surveill"},{"issue":"24","key":"10.1016\/j.hoc.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2019.05.002_bib17","series-title":"Donor screening recommendations to reduce the risk of transmission of Zika virus by human cells, tissues, and cellular and tissue-based products","author":"Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.hoc.2019.05.002_bib18","series-title":"Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components","author":"Food and Drug Administration","year":"2016"},{"issue":"19","key":"10.1016\/j.hoc.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa1714977","article-title":"Investigational testing for Zika virus among U.S. Blood donors","volume":"378","author":"Saa","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2019.05.002_bib20","series-title":"FDA announces revised guidance on the testing of donated blood and blood components for Zika virus","author":"Food and Drug Administration","year":"2018"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0887-7963(91)70194-6","article-title":"Blood product-associated bacterial sepsis","volume":"5","author":"Goldman","year":"1991","journal-title":"Transfus Med Rev"},{"issue":"5","key":"10.1016\/j.hoc.2019.05.002_bib22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1537-2995.2005.04363.x","article-title":"Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion","volume":"45","author":"Leclercq","year":"2005","journal-title":"Transfusion"},{"issue":"8391","key":"10.1016\/j.hoc.2019.05.002_bib23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(84)91891-9","article-title":"Five cases of pseudomonas sepsis transmitted by blood transfusions","volume":"1","author":"Tabor","year":"1984","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1537-2995.2000.40080931.x","article-title":"Transfusion-related sepsis due to Serratia liquefaciens in the United States","volume":"40","author":"Roth","year":"2000","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2019.05.002_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2015-07-655944","article-title":"Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance","volume":"127","author":"Hong","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1537-2995.2009.02192.x","article-title":"Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety","volume":"49","author":"Eder","year":"2009","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib27","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/trf.12593","article-title":"Staphylococcus aureus sepsis from one cocomponent of a \"triple\" apheresis platelet donation","volume":"54","author":"Kaufman","year":"2014","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1086\/529143","article-title":"Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets","volume":"46","author":"Jacobs","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1537-2995.2011.03083.x","article-title":"How do I investigate septic transfusion reactions and blood donors with culture-positive platelet donations?","volume":"51","author":"Eder","year":"2011","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.hoc.2019.05.002_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1537-2995.2006.00746.x","article-title":"Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands","volume":"46","author":"de Korte","year":"2006","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.hoc.2019.05.002_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1537-2995.2010.02868.x","article-title":"Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets","volume":"51","author":"Benjamin","year":"2011","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib32","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1537-2995.2010.03001.x","article-title":"Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection","volume":"51","author":"Robillard","year":"2011","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.hoc.2019.05.002_bib33","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1537-2995.2008.01763.x","article-title":"Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system","volume":"48","author":"Su","year":"2008","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1537-2995.2007.01248.x","article-title":"Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)","volume":"47","author":"Eder","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.hoc.2019.05.002_bib35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1537-2995.2007.01132.x","article-title":"A\u00a0model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume","volume":"47","author":"Wagner","year":"2007","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.hoc.2019.05.002_bib36","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1537-2995.2005.00650.x","article-title":"Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004","volume":"45","author":"Fang","year":"2005","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/vox.12065","article-title":"Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results","volume":"106","author":"Benjamin","year":"2014","journal-title":"Vox Sang"},{"issue":"10","key":"10.1016\/j.hoc.2019.05.002_bib38","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/JCM.00542-10","article-title":"The Pan Genera Detection immunoassay: a novel point-of-issue method for detection of bacterial contamination in platelet concentrates","volume":"48","author":"Vollmer","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.hoc.2019.05.002_bib39","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/j.1537-2995.2011.03308.x","article-title":"Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test","volume":"51","author":"Jacobs","year":"2011","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/trf.14618","article-title":"Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions","volume":"58","author":"Bloch","year":"2018","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1423-0410.2008.01051.x","article-title":"Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety","volume":"95","author":"Murphy","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.hoc.2019.05.002_bib42","series-title":"Blood products advisory meeting. Transcripts","author":"Food and Drug Administration","year":"2018"},{"issue":"5","key":"10.1016\/j.hoc.2019.05.002_bib43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/trf.14085","article-title":"Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure","volume":"57","author":"McDonald","year":"2017","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00022-10","article-title":"Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti","volume":"24","author":"Leiby","year":"2011","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib45","first-page":"11","article-title":"Piroplasmosis in man; report of a case","volume":"9","author":"Skrabalo","year":"1957","journal-title":"Doc Med Geogr Trop"},{"issue":"25","key":"10.1016\/j.hoc.2019.05.002_bib46","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis","volume":"366","author":"Vannier","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hoc.2019.05.002_bib47","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJM200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis","volume":"343","author":"Krause","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-155-8-201110180-00362","article-title":"Transfusion-associated babesiosis in the United States: a description of cases","volume":"155","author":"Herwaldt","year":"2011","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.hoc.2019.05.002_bib49","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7326\/0003-4819-148-10-200805200-00018","article-title":"Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease","volume":"148","author":"Cirino","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.hoc.2019.05.002_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tmrv.2016.04.002","article-title":"Transfusion-transmitted Babesia microti","volume":"30","author":"Fang","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26734","article-title":"Transfusion-transmitted babesiosis leading to severe hemolysis in two patients with sickle cell anemia","volume":"65","author":"Karkoska","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib52","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1537-2995.2011.03467.x","article-title":"The third described case of transfusion-transmitted Babesia duncani","volume":"52","author":"Bloch","year":"2012","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2019.05.002_bib53","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)","volume":"54","author":"Vichinsky","year":"2014","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2019.05.002_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/trf.15043","article-title":"The impact of Babesia microti blood donation screening","volume":"59","author":"Tonnetti","year":"2019","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1537-2995.2012.03612.x","article-title":"Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program","volume":"52","author":"Young","year":"2012","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.hoc.2019.05.002_bib56","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1111\/trf.15009","article-title":"You can't get CMV from a blood transfusion: 2017 Emily Cooley award lecture","volume":"58","author":"Goldfinger","year":"2018","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2019.05.002_bib57","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1537-2995.2003.00426.x","article-title":"WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials","volume":"43","author":"Vamvakas","year":"2003","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.hoc.2019.05.002_bib58","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A\u00a0comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2019.05.002_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/vox.12250","article-title":"The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components","volume":"109","author":"Seed","year":"2015","journal-title":"Vox Sang"},{"issue":"12","key":"10.1016\/j.hoc.2019.05.002_bib60","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1537-2995.2011.03203.x","article-title":"Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME)","volume":"51","author":"Thiele","year":"2011","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.hoc.2019.05.002_bib61","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jamapediatrics.2014.1360","article-title":"Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study","volume":"168","author":"Josephson","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.hoc.2019.05.002_bib62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/trf.12945","article-title":"Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products","volume":"55","author":"Keil","year":"2015","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.hoc.2019.05.002_bib63","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1537-2995.2004.03351.x","article-title":"Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model","volume":"44","author":"Jordan","year":"2004","journal-title":"Transfusion"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:13:17Z","timestamp":1760184797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858819300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0889858819300607"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2019.05.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Existing and Emerging Blood-Borne Pathogens","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}